Adrienne L. Graves - 22 Oct 2024 Form 4 Insider Report for Opus Genetics, Inc. (IRD)

Role
Director
Signature
/s/ Amy Rabourn, by Power of Attorney
Issuer symbol
IRD
Transactions as of
22 Oct 2024
Net transactions value
$0
Form type
4
Filing time
24 Oct 2024, 17:59:15 UTC
Previous filing
26 Jul 2024
Next filing
02 May 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRD Stock Option (right to buy) Award $0 +172,874 $0.000000 172,874 22 Oct 2024 Common Stock 172,874 $1.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest in a series of three equal annual installments over the three-year period measured from the grant date of October 22, 2024, subject to the Reporting Person's continuing service.